Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma

CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450

Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research